TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Nucleic Acid Based Gene Therapy Market Research Report 2024(Status and Outlook)

Global Nucleic Acid Based Gene Therapy Market Research Report 2024(Status and Outlook)

  • Category:Life Sciences
  • Published on : 01 February 2024
  • Pages :129
  • Formats:
  • Report Code:SMR-7894776
OfferClick for best price

Best Price: $2560

Nucleic Acid Based Gene Therapy Market Size, Share 2024


Report Overview:

Gene therapy is used for correcting defective genes that are responsible for disease development. Moreover, nucleic acid-based therapeutics are used to treat genetic disorders and diseases for which there exists no permanent cure such as anaemia, sickle cell, cystic fibrosis, diabetes, and thalassemia.

The Global Nucleic Acid Based Gene Therapy Market Size was estimated at USD 4974.44 million in 2023 and is projected to reach USD 8764.57 million by 2029, exhibiting a CAGR of 9.90% during the forecast period.

This report provides a deep insight into the global Nucleic Acid Based Gene Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter?s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Nucleic Acid Based Gene Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Nucleic Acid Based Gene Therapy market in any manner.

Global Nucleic Acid Based Gene Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Wave Life Sciences

Imugene

Sarepta Therapeutics

Alnylam Pharmaceuticals

Ionis Pharmaceuticals

Moderna

BioNTech

Nutcracker Therapeutics

Deep Genomics

Sirnaomics

Laronde

Abogen Biosciences

Market Segmentation (by Type)

Anti-Sence and Anti-Gene

Short Inhibitory Sequences

Gene Transfer Therapy

Nucleoside Analogs

Ribozymes

Aptamers

Others

Market Segmentation (by Application)

Hospitals and Clinics

Academic and Research Institutes

Others

Geographic Segmentation

? North America (USA, Canada, Mexico)

? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

? South America (Brazil, Argentina, Columbia, Rest of South America)

? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

? Industry drivers, restraints, and opportunities covered in the study

? Neutral perspective on the market performance

? Recent industry trends and developments

? Competitive landscape & strategies of key players

? Potential & niche segments and regions exhibiting promising growth covered

? Historical, current, and projected market size, in terms of value

? In-depth analysis of the Nucleic Acid Based Gene Therapy Market

? Overview of the regional outlook of the Nucleic Acid Based Gene Therapy Market:

Key Reasons to Buy this Report:

? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

? This enables you to anticipate market changes to remain ahead of your competitors

? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

? Provision of market value (USD Billion) data for each segment and sub-segment

? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis

? Provides insight into the market through Value Chain

? Market dynamics scenario, along with growth opportunities of the market in the years to come

? 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nucleic Acid Based Gene Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Report Attributes Report Details
Report Title Global Nucleic Acid Based Gene Therapy Market Research Report 2024(Status and Outlook)
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2023
Forecast Year 2031
Number of Pages 129 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Nucleic Acid Based Gene Therapy
1.2 Key Market Segments
1.2.1 Nucleic Acid Based Gene Therapy Segment by Type
1.2.2 Nucleic Acid Based Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Nucleic Acid Based Gene Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Nucleic Acid Based Gene Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Nucleic Acid Based Gene Therapy Market Competitive Landscape
3.1 Global Nucleic Acid Based Gene Therapy Sales by Manufacturers (2019-2024)
3.2 Global Nucleic Acid Based Gene Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Nucleic Acid Based Gene Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Nucleic Acid Based Gene Therapy Sales Sites, Area Served, Product Type
3.6 Nucleic Acid Based Gene Therapy Market Competitive Situation and Trends
3.6.1 Nucleic Acid Based Gene Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Nucleic Acid Based Gene Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.1 Nucleic Acid Based Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Nucleic Acid Based Gene Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Nucleic Acid Based Gene Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2019-2024)
6.3 Global Nucleic Acid Based Gene Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Nucleic Acid Based Gene Therapy Price by Type (2019-2024)
7 Nucleic Acid Based Gene Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nucleic Acid Based Gene Therapy Market Sales by Application (2019-2024)
7.3 Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2024)
8 Nucleic Acid Based Gene Therapy Market Segmentation by Region
8.1 Global Nucleic Acid Based Gene Therapy Sales by Region
8.1.1 Global Nucleic Acid Based Gene Therapy Sales by Region
8.1.2 Global Nucleic Acid Based Gene Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Nucleic Acid Based Gene Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Nucleic Acid Based Gene Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Nucleic Acid Based Gene Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Nucleic Acid Based Gene Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Wave Life Sciences
9.1.1 Wave Life Sciences Nucleic Acid Based Gene Therapy Basic Information
9.1.2 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
9.1.3 Wave Life Sciences Nucleic Acid Based Gene Therapy Product Market Performance
9.1.4 Wave Life Sciences Business Overview
9.1.5 Wave Life Sciences Nucleic Acid Based Gene Therapy SWOT Analysis
9.1.6 Wave Life Sciences Recent Developments
9.2 Imugene
9.2.1 Imugene Nucleic Acid Based Gene Therapy Basic Information
9.2.2 Imugene Nucleic Acid Based Gene Therapy Product Overview
9.2.3 Imugene Nucleic Acid Based Gene Therapy Product Market Performance
9.2.4 Imugene Business Overview
9.2.5 Imugene Nucleic Acid Based Gene Therapy SWOT Analysis
9.2.6 Imugene Recent Developments
9.3 Sarepta Therapeutics
9.3.1 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Basic Information
9.3.2 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
9.3.3 Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
9.3.4 Sarepta Therapeutics Nucleic Acid Based Gene Therapy SWOT Analysis
9.3.5 Sarepta Therapeutics Business Overview
9.3.6 Sarepta Therapeutics Recent Developments
9.4 Alnylam Pharmaceuticals
9.4.1 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
9.4.2 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
9.4.3 Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
9.4.4 Alnylam Pharmaceuticals Business Overview
9.4.5 Alnylam Pharmaceuticals Recent Developments
9.5 Ionis Pharmaceuticals
9.5.1 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
9.5.2 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
9.5.3 Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Market Performance
9.5.4 Ionis Pharmaceuticals Business Overview
9.5.5 Ionis Pharmaceuticals Recent Developments
9.6 Moderna
9.6.1 Moderna Nucleic Acid Based Gene Therapy Basic Information
9.6.2 Moderna Nucleic Acid Based Gene Therapy Product Overview
9.6.3 Moderna Nucleic Acid Based Gene Therapy Product Market Performance
9.6.4 Moderna Business Overview
9.6.5 Moderna Recent Developments
9.7 BioNTech
9.7.1 BioNTech Nucleic Acid Based Gene Therapy Basic Information
9.7.2 BioNTech Nucleic Acid Based Gene Therapy Product Overview
9.7.3 BioNTech Nucleic Acid Based Gene Therapy Product Market Performance
9.7.4 BioNTech Business Overview
9.7.5 BioNTech Recent Developments
9.8 Nutcracker Therapeutics
9.8.1 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Basic Information
9.8.2 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
9.8.3 Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Market Performance
9.8.4 Nutcracker Therapeutics Business Overview
9.8.5 Nutcracker Therapeutics Recent Developments
9.9 Deep Genomics
9.9.1 Deep Genomics Nucleic Acid Based Gene Therapy Basic Information
9.9.2 Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
9.9.3 Deep Genomics Nucleic Acid Based Gene Therapy Product Market Performance
9.9.4 Deep Genomics Business Overview
9.9.5 Deep Genomics Recent Developments
9.10 Sirnaomics
9.10.1 Sirnaomics Nucleic Acid Based Gene Therapy Basic Information
9.10.2 Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
9.10.3 Sirnaomics Nucleic Acid Based Gene Therapy Product Market Performance
9.10.4 Sirnaomics Business Overview
9.10.5 Sirnaomics Recent Developments
9.11 Laronde
9.11.1 Laronde Nucleic Acid Based Gene Therapy Basic Information
9.11.2 Laronde Nucleic Acid Based Gene Therapy Product Overview
9.11.3 Laronde Nucleic Acid Based Gene Therapy Product Market Performance
9.11.4 Laronde Business Overview
9.11.5 Laronde Recent Developments
9.12 Abogen Biosciences
9.12.1 Abogen Biosciences Nucleic Acid Based Gene Therapy Basic Information
9.12.2 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
9.12.3 Abogen Biosciences Nucleic Acid Based Gene Therapy Product Market Performance
9.12.4 Abogen Biosciences Business Overview
9.12.5 Abogen Biosciences Recent Developments
10 Nucleic Acid Based Gene Therapy Market Forecast by Region
10.1 Global Nucleic Acid Based Gene Therapy Market Size Forecast
10.2 Global Nucleic Acid Based Gene Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Nucleic Acid Based Gene Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Nucleic Acid Based Gene Therapy Market Size Forecast by Region
10.2.4 South America Nucleic Acid Based Gene Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Nucleic Acid Based Gene Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Nucleic Acid Based Gene Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Nucleic Acid Based Gene Therapy by Type (2025-2030)
11.1.2 Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Nucleic Acid Based Gene Therapy by Type (2025-2030)
11.2 Global Nucleic Acid Based Gene Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Nucleic Acid Based Gene Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Nucleic Acid Based Gene Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

LIST OF TABLES & FIGURES

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Nucleic Acid Based Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Nucleic Acid Based Gene Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Nucleic Acid Based Gene Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Nucleic Acid Based Gene Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Nucleic Acid Based Gene Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Based Gene Therapy as of 2022)
Table 10. Global Market Nucleic Acid Based Gene Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Nucleic Acid Based Gene Therapy Sales Sites and Area Served
Table 12. Manufacturers Nucleic Acid Based Gene Therapy Product Type
Table 13. Global Nucleic Acid Based Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Nucleic Acid Based Gene Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nucleic Acid Based Gene Therapy Market Challenges
Table 22. Global Nucleic Acid Based Gene Therapy Sales by Type (Kilotons)
Table 23. Global Nucleic Acid Based Gene Therapy Market Size by Type (M USD)
Table 24. Global Nucleic Acid Based Gene Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Nucleic Acid Based Gene Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Nucleic Acid Based Gene Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Nucleic Acid Based Gene Therapy Market Size Share by Type (2019-2024)
Table 28. Global Nucleic Acid Based Gene Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Nucleic Acid Based Gene Therapy Sales (Kilotons) by Application
Table 30. Global Nucleic Acid Based Gene Therapy Market Size by Application
Table 31. Global Nucleic Acid Based Gene Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Nucleic Acid Based Gene Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Nucleic Acid Based Gene Therapy Market Share by Application (2019-2024)
Table 35. Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Nucleic Acid Based Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Nucleic Acid Based Gene Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Nucleic Acid Based Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Nucleic Acid Based Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Nucleic Acid Based Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Nucleic Acid Based Gene Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Nucleic Acid Based Gene Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Wave Life Sciences Nucleic Acid Based Gene Therapy Basic Information
Table 44. Wave Life Sciences Nucleic Acid Based Gene Therapy Product Overview
Table 45. Wave Life Sciences Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Wave Life Sciences Business Overview
Table 47. Wave Life Sciences Nucleic Acid Based Gene Therapy SWOT Analysis
Table 48. Wave Life Sciences Recent Developments
Table 49. Imugene Nucleic Acid Based Gene Therapy Basic Information
Table 50. Imugene Nucleic Acid Based Gene Therapy Product Overview
Table 51. Imugene Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Imugene Business Overview
Table 53. Imugene Nucleic Acid Based Gene Therapy SWOT Analysis
Table 54. Imugene Recent Developments
Table 55. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Basic Information
Table 56. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Product Overview
Table 57. Sarepta Therapeutics Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sarepta Therapeutics Nucleic Acid Based Gene Therapy SWOT Analysis
Table 59. Sarepta Therapeutics Business Overview
Table 60. Sarepta Therapeutics Recent Developments
Table 61. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
Table 62. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
Table 63. Alnylam Pharmaceuticals Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Alnylam Pharmaceuticals Business Overview
Table 65. Alnylam Pharmaceuticals Recent Developments
Table 66. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Basic Information
Table 67. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Product Overview
Table 68. Ionis Pharmaceuticals Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Ionis Pharmaceuticals Business Overview
Table 70. Ionis Pharmaceuticals Recent Developments
Table 71. Moderna Nucleic Acid Based Gene Therapy Basic Information
Table 72. Moderna Nucleic Acid Based Gene Therapy Product Overview
Table 73. Moderna Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Moderna Business Overview
Table 75. Moderna Recent Developments
Table 76. BioNTech Nucleic Acid Based Gene Therapy Basic Information
Table 77. BioNTech Nucleic Acid Based Gene Therapy Product Overview
Table 78. BioNTech Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. BioNTech Business Overview
Table 80. BioNTech Recent Developments
Table 81. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Basic Information
Table 82. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Product Overview
Table 83. Nutcracker Therapeutics Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Nutcracker Therapeutics Business Overview
Table 85. Nutcracker Therapeutics Recent Developments
Table 86. Deep Genomics Nucleic Acid Based Gene Therapy Basic Information
Table 87. Deep Genomics Nucleic Acid Based Gene Therapy Product Overview
Table 88. Deep Genomics Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. Deep Genomics Business Overview
Table 90. Deep Genomics Recent Developments
Table 91. Sirnaomics Nucleic Acid Based Gene Therapy Basic Information
Table 92. Sirnaomics Nucleic Acid Based Gene Therapy Product Overview
Table 93. Sirnaomics Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Sirnaomics Business Overview
Table 95. Sirnaomics Recent Developments
Table 96. Laronde Nucleic Acid Based Gene Therapy Basic Information
Table 97. Laronde Nucleic Acid Based Gene Therapy Product Overview
Table 98. Laronde Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Laronde Business Overview
Table 100. Laronde Recent Developments
Table 101. Abogen Biosciences Nucleic Acid Based Gene Therapy Basic Information
Table 102. Abogen Biosciences Nucleic Acid Based Gene Therapy Product Overview
Table 103. Abogen Biosciences Nucleic Acid Based Gene Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Abogen Biosciences Business Overview
Table 105. Abogen Biosciences Recent Developments
Table 106. Global Nucleic Acid Based Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Nucleic Acid Based Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Nucleic Acid Based Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Nucleic Acid Based Gene Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Nucleic Acid Based Gene Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Nucleic Acid Based Gene Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Nucleic Acid Based Gene Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Nucleic Acid Based Gene Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Nucleic Acid Based Gene Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Nucleic Acid Based Gene Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Nucleic Acid Based Gene Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Nucleic Acid Based Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nucleic Acid Based Gene Therapy Market Size (M USD), 2019-2030
Figure 5. Global Nucleic Acid Based Gene Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Nucleic Acid Based Gene Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nucleic Acid Based Gene Therapy Market Size by Country (M USD)
Figure 11. Nucleic Acid Based Gene Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Nucleic Acid Based Gene Therapy Revenue Share by Manufacturers in 2023
Figure 13. Nucleic Acid Based Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Nucleic Acid Based Gene Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid Based Gene Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Nucleic Acid Based Gene Therapy Market Share by Type
Figure 18. Sales Market Share of Nucleic Acid Based Gene Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Nucleic Acid Based Gene Therapy by Type in 2023
Figure 20. Market Size Share of Nucleic Acid Based Gene Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Nucleic Acid Based Gene Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Nucleic Acid Based Gene Therapy Market Share by Application
Figure 24. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Nucleic Acid Based Gene Therapy Sales Market Share by Application in 2023
Figure 26. Global Nucleic Acid Based Gene Therapy Market Share by Application (2019-2024)
Figure 27. Global Nucleic Acid Based Gene Therapy Market Share by Application in 2023
Figure 28. Global Nucleic Acid Based Gene Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Nucleic Acid Based Gene Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Nucleic Acid Based Gene Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Nucleic Acid Based Gene Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Nucleic Acid Based Gene Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Nucleic Acid Based Gene Therapy Sales Market Share by Country in 2023
Figure 37. Germany Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Nucleic Acid Based Gene Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Nucleic Acid Based Gene Therapy Sales Market Share by Region in 2023
Figure 44. China Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Nucleic Acid Based Gene Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Nucleic Acid Based Gene Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Nucleic Acid Based Gene Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Nucleic Acid Based Gene Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Nucleic Acid Based Gene Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Nucleic Acid Based Gene Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Nucleic Acid Based Gene Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Nucleic Acid Based Gene Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Nucleic Acid Based Gene Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Nucleic Acid Based Gene Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Nucleic Acid Based Gene Therapy Market Share Forecast by Application (2025-2030)

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount